carmustine medac (previously carmustine obvius)
medac gesellschaft für klinische spezialpräparate mbh - carmustine - hodgkin disease; lymphoma, non-hodgkin - antinavikiniai vaistai - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).
carmustine zentiva [carmustine tillomed]
zentiva k.s. - karmustinas - milteliai ir tirpiklis infuzinio tirpalo koncentratui - 100 mg - carmustine
clemastinum pph [clemastinum wzf polfa]
zakłady farmaceutyczne polpharma s.a. - klemastinas - tabletės - 1 mg - clemastine
clemastinum pph [clemastinum wzf polfa]
zakłady farmaceutyczne polpharma s.a. - klemastinas - sirupas - 0,1 mg/ml - clemastine
tavegyl
stada arzneimittel ag - klemastinas - tabletės - 1 mg/ml; 1 mg - clemastine
tavegyl
actiofarma, uab - klemastinas - injekcinis tirpalas - 1 mg/ml - clemastine
clemastinum wzf
actiofarma, uab - klemastinas - injekcinis tirpalas - 1 mg/ml - clemastine
clemastinum hasco
lex ano, uab - klemastinas - tabletės - 1 mg - clemastine
clemastinum wzf
adeofarma, uab - klemastinas - injekcinis tirpalas - 1 mg/ml - clemastine
clemastinum wzf
ideal trade links, iĮ - klemastinas - injekcinis tirpalas - 1 mg/ml - clemastine